Adagrasib Plus Cetuximab Shows Promise for Patients With KRAS-Mutated Colorectal Cancer
LAG-3 and PD-1 Inhibitors for Esophageal and Gastroesophageal Junction Cancer: A Phase Ib Trial
Combining Gemcitabine With CXCR4, PD-1 Inhibitors for Pancreatic Ductal Adenocarcinoma